As has been the experience with other institutions that have responded to this question, I believe that having the patients buy the prep would result in poor compliance. I should have mentioned in my initial note that even when we do not have patients take the Simethicone we are still able to successfully perform a complete study. What does makes a significant difference is whether or not the patient is NPO. I think that we're simply going to continue to emphasize the NPO instructions and altogether eliminate the use of Simethicone. It is simply too risky legally especially when not using does not necessarily alter our test outcome. Thanks to all who provided us input.
>>> T Cunningham <[log in to unmask]> 05/14/99 06:31PM >>>
Why not just advise the patients to buy the prep.?
You could also advise them to check with the pharmacist to exclude any
potential contraindications with their medications.
That way you are covered legally and are getting the study that you want.